IV Endocrine, nutritional and metabolic diseases. E11
Conditions
Interventions
Intervention 1: A double-blind randomized clinical trial of parallel design was used. During a 2-week baseline period, participants continued their usual diet without any cranberry (Run-in period), th
Treatment - Other
Treatment - Drugs
A double-blind randomized clinical trial of parallel design was used. During a 2-week baseline period, participants continued their usual diet without any cranberry (Run-in period), then in interventi
A double-blind randomized clinical trial of parallel design was used. During a 2-week baseline period, participants continued their usual diet without any cranberry (Run-in period), then in control gr
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
25 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: BMI more than 30 kg/m2; HbAlc less than 9% ; serum triglyceride 1.62 mg/d1) or thyroid disease; use of steroids or drugs with unknown components ; change in the use of medication for diabetes ; hypertension ; dyslipidemia or anti-platelet in the previous 2 months ; pregnancy or reastfeeding.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lp(a). Timepoint: 12 weeks. Method of measurement: Laboratory kits.;Glucose. Timepoint: 12 weeks. Method of measurement: laboratory kits.;Paraoxonase-1. Timepoint: 12 weeks. Method of measurement: Laboratory kits.;ApoB. Timepoint: 12 weeks. Method of measurement: laboratory kits.;Apoa-I. Timepoint: 12 weeks. Method of measurement: laboratory kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: 12 weeks. Method of measurement: electronic scale.;Body mass index. Timepoint: 12 weeks. Method of measurement: Weight/height2.;Waist circumference. Timepoint: 12 weeks. Method of measurement: nonstrechable tape. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzad Shidfar
Tehran University of Medical sciences
Outcome results
None listed